AMGN34:BVMF
Amgen Inc. BDR
R$74.27
0.00%
(0.00) 1D
Okt 9, 4:56:00 PM GMT-3 · BRL
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa AMGN34...
Buksan
R$74.09
Mataas
R$74.48
Mababa
R$73.22
Mkt. cap
224.29B
Avg. na dami
434.00
Dami
74.00
Mataas nang 52-wk
R$83.06
Mababa nang 52-wk
R$47.76
Mga natitirang share
540.63M
Bilang ng mga empleyado
32K
Buksan
R$74.09
Mataas
R$74.48
Mababa
R$73.22
Mkt. cap
224.29B
Avg. na dami
434.00
Dami
74.00
Mataas nang 52-wk
R$83.06
Mababa nang 52-wk
R$47.76
Mga natitirang share
540.63M
Bilang ng mga empleyado
32K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Simply Wall Street
·
2 oras ang nakalipas
Amgen (AMGN) Stock Could Be 39% Undervalued Following KRAS Market Growth
MarketBeat
·
1 araw ang nakalipas
Amgen Inc. $AMGN Stock Sold by Castle Rock Wealth Management LLC
MarketWatch
·
1 araw ang nakalipas
Amgen Inc. stock underperforms Friday when compared to competitors despite daily gains
AD HOC NEWS
·
1 araw ang nakalipas
Cantor Fitzgerald raises target for Amgen stock from USD 400 to USD 440
Profile
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Tungkol sa Amgen Inc. BDR
CEORobert A. Bradway
Mga Empleyado31.5K
Itinatag1980
HeadquartersThousand Oaks, California, Estados Unidos
Sektor-
Websiteamgen.com